Supply Chains Still the Biggest Issue When Sourcing Comparators for Trials
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
With healthcare's growing emphasis on the comparative effectiveness of new drugs in relation to what is already available, recent times have brought forth an expectation for developers to prove additional benefits at the clinical trial stage. But with more and more studies being conducted on a global scale, the process of sourcing comparators is fraught with difficulty.
According to a poll conducted by Pharma IQ, ahead of next year's Clinical Trial Supply Europe event in Switzerland, complex supply chains are still the biggest challenge for drug developers trying to source comparators for clinical trials. Generally speaking, there are two main issues holding back the supply of comparator drugs – security and time delays.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.